Mengmeng Zhao

A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma.

Q. Zhai, Xianhuo Wang, B. Meng, 2022, Clinical immunology.

Metabolism-associated molecular classification of gastric adenocarcinoma

Xin Wang, Fangrong Yan, Xiaofan Lu, 2022, Frontiers in Oncology.

Comprehensive analysis of TP53 mutation characteristics and identification of patients with inferior prognosis and enhanced immune escape in diffuse large B‐cell lymphoma

Q. Zhai, Xianhuo Wang, B. Meng, 2021, American journal of hematology.

Integration of scRNA-seq and bulk RNA-seq constructs a stemness-related signature for predicting prognosis and immunotherapy responses in hepatocellular carcinoma

Jingya Fang, Fangrong Yan, Guanjie Li, 2023, Journal of Cancer Research and Clinical Oncology.